Clinical Trials Browser

Phase 4 × Completed × Nivolumab × Clear all

NCT02626065 2025-09-15

PAIR

Phase 4 Completed

Melanoma

NCT04513522 2025-07-11

CheckMate 7C9

Phase 4 Completed

101 enrolled 12 charts

Kidney Neoplasms

NCT02869789 2023-06-15

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

Phase 4 Completed

1,041 enrolled 18 charts

Lung Neoplasms

NCT02982954 2022-11-01

CHECKMATE 920

Phase 4 Completed

211 enrolled 21 charts

Carcinoma, Renal Cell

NCT02596035 2022-10-27

CheckMate 374

Phase 4 Completed

197 enrolled 16 charts

Carcinoma, Renal Cell

NCT04707547 2021-01-13

RFA

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

Phase 4 Completed

100 enrolled 12 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms